JUNS
Jupiter Neurosciences (JUNS)
$10
About Jupiter Neurosciences (JUNS)
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Details
Daily high
$1.20
Daily low
$1.10
Price at open
$1.12
52 Week High
$12.81
52 Week Low
$0.51
Market cap
37.9M
Dividend yield
0.00%
Volume
60,431
Avg. volume
40,387
P/E ratio
-4.84
Jupiter Neurosciences News
Details
Daily high
$1.20
Daily low
$1.10
Price at open
$1.12
52 Week High
$12.81
52 Week Low
$0.51
Market cap
37.9M
Dividend yield
0.00%
Volume
60,431
Avg. volume
40,387
P/E ratio
-4.84